Alberta Respiratory Centre

marchant-paper-image.jpg
Paper in Nature: IGF1R is an entry receptor for respiratory syncytial virus
Congratulations to Dr. David Marchant, Assistant Professor in Medical Microbiology and Immunology, and member of ARC, in publishing a paper in Nature, one of the world's top journals. The paper examines a novel entry receptor for respiratory syncytial virus (RSV), a major respiratory virus responsible for the deaths of many children around the world. This discovery will help us devise new therapeutic strategies for the treatment of RSV infections. See more News and Events

 

Suffocating summers new normal for asthmatic children in Alberta

ARC Director Anne Hicks gives expert comment on CBC about respiratory illness management for children in an era of climate change and wildfires.

Innovative patient-centered lung clinic reduces suffering along with costs

Multidisciplinary Interstitial Lung Disease Clinic delivers palliative care and encourages treatment at home for patients with idiopathic pulmonary fibrosis.